The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Arbutus Biopharma Corp (NASDAQ: ABUS) closed at $3.51 in the last session, up 0.86% from day before closing price of $3.48. In other words, the price has increased by $0.86 from its previous closing price. On the day, 1.32 million shares were traded. ABUS stock price reached its highest trading level at $3.605 during the session, while it also had its lowest trading level at $3.465.
Ratios:
We take a closer look at ABUS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.15 and its Current Ratio is at 8.15. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 25, 2021, Jefferies started tracking the stock assigning a Hold rating and target price of $5.
On December 17, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on December 17, 2020, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when Sofia Michael J. bought 250,000 shares for $3.50 per share.
Sofia Michael J. bought 250,000 shares of ABUS for $820,000 on Mar 24 ’25. On Mar 19 ’25, another insider, Sofia Michael J., who serves as the Officer of the company, bought 150,000 shares for $3.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABUS now has a Market Capitalization of 672094784 and an Enterprise Value of 555590464. For the stock, the TTM Price-to-Sale (P/S) ratio is 108.93 while its Price-to-Book (P/B) ratio in mrq is 6.85. Its current Enterprise Value per Revenue stands at 90.032 whereas that against EBITDA is -7.683.
Stock Price History:
The Beta on a monthly basis for ABUS is 1.50, which has changed by 0.16999996 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, ABUS has reached a high of $4.72, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 4.71%, while the 200-Day Moving Average is calculated to be -2.30%.
Shares Statistics:
According to the various share statistics, ABUS traded on average about 887.28K shares per day over the past 3-months and 1172040 shares per day over the past 10 days. A total of 189.96M shares are outstanding, with a floating share count of 148.63M. Insiders hold about 22.38% of the company’s shares, while institutions hold 54.38% stake in the company. Shares short for ABUS as of 1741910400 were 9574515 with a Short Ratio of 10.79, compared to 1739491200 on 7212196. Therefore, it implies a Short% of Shares Outstanding of 9574515 and a Short% of Float of 6.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
